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Varicose veinsAbstract Purpose: To assess the value of endovenous laser ablation as a treatment of varicose
veins.
Materials and methods: Study included 30 patients (22 females, 8 males) with a mean age of
38.4 years (age range from 25 to 55 years) presented with varicose vein caused by saphenofemoral
junction (SFJ) incompetence with Great Saphenous Vein (GSV) reflux. Patients underwent Endove-
nous Laser Therapy (EVLT) with 980-nm diode laser as an outpatient procedure. Patients were re-
examined one week, 1, 2 and 3 months postprocedure.
Results: Immediate postoperative successful occlusion that is defined as absence of flow by duplex
ultrasound, was achieved in 29 GSVs (97%). Failure occurred in one case with large vein (GSV
diameter > 0.8 cm). The procedure was well tolerated by all patients. The mean GSV diameter
measured in upright position, was 6.5 mm (range from 4 to 9 mm). The mean length of treated
GSV was 44.2 cm (range from 38 to 50 cm). Ecchymosis was seen in 18 patients (72%). Indurations
were observed in 2 patients (6%) and resolved within two weeks. No paresthesia, superficial burns
or DVT was detected.
Conclusion: Endovenous laser ablation for GSV reflux is a safe, feasible and efficient outpatient
technique.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).1. Introduction
Lower extremity venous insufficiency is a heterogeneous med-
ical condition whose spectrum ranges from cosmetic abnor-
malities including spider telangiectasias to varicose veins with
or without associated signs and symptoms including severe
edema, skin ulceration, and subsequent major disability.
Venous hypertension caused by incompetent valves in the
superficial veins is by far the most common cause of this con-
dition. It is expected that approximately 25% of women and
180 M.G. Eissawy et al.15% of men have lower extremity superficial venous insuffi-
ciency (1). Great Saphenous Vein (GSV) reflux is the most
common underlying cause of significant varicose veins (1).
Although surgical treatment of varicose veins is the traditional
one, it has a 30–60% recurrence rate (2,3). The possible mech-
anisms of recurrence after surgical treatment are inadequate
procedure and neorevascularization at the junctional area (4).
When the GSV reflux is the principal underlying problem,
treatment should involve eliminating this source of reflux with
ablation of any associated incompetent venous segment (5).
Endovenous Laser Therapy (EVLT) is one of the most
promising techniques which was firstly introduced in 1998 by
Spanish phlebologist, Carlos Bone (5). Diode lasers are most
commonly used for ELA (6). Different varieties of wavelengths
have been proposed. Wavelengths 810, 940 and 980 nm are the
most commonly used with a power energy set between 10 and
15 W (7–10). These types of wavelengths induce heating of the
venous wall which leads to luminal contraction, venous throm-
bosis, and vein fibrosis (11). Tumescent anesthesia is a must
during the procedure, so patients feel no pain during the pro-
cedure. Tumescent anesthesia also has additional two advan-
tages of compressing the vein and minimizing its diameter to
provide vein wall apposition around the fiber tip and act as
a protective barrier to minimize the risk of heat-related dam-
age to adjacent structures (12).
The aim of our study was to assess Endovenous Laser Ther-
apy in the treatment of patients with varicose veins due to GSV
reflux and incompetence of the GSV as an alternative to GSV
stripping.Fig. 1 Endovascular laser set.2. Patients and methods
This prospective study was carried out during the time period
from June 2011 to January 2013 on 30 patients (22 females, 8
males) with a mean age of 38.4 years (range from 25 to
55 years) presented by varicose vein due to saphenofemoral
junction (SFJ) incompetence and GSV reflux that was
detected by duplex study. These patients underwent EVLT
with 980-nm diode laser and followed up for a duration of
12 months. The study was approved by ethical committee
of our hospital. Patients with tortuous GSV that could not
allow passage of the sheath, laser fiber, non-palpable distal
pulsation, inability to ambulate, patients with previous his-
tory of deep venous thrombosis (DVT) and pregnant women
were excluded from the study. All patients were subjected to
detailed history, physical examination, and duplex ultrasound
imaging.
2.1. Procedure
Color duplex ultrasonography (Mindray, China) with a 8 MHz
probe was performed in the upright position to map incompe-
tent sources of venous reflux and mark the skin overlying
GSV starting at the SFJ.GSVdiameter wasmeasured in upright
position in different sites e.g. 2–3 cm below the SFJ, mid-thigh
and at the knee level in standing position and recorded. The pro-
cedurewas done in special operative theater respecting the safety
precautions of using laser. The target extremity was sterilized
and draped. Patient was placed in reversed Trendelenburg posi-
tion to facilitate cannulation of GSV either directly or under
ultrasound guidance. The site of puncture was few centimetersbelow the knee level with a 18-gauge cannula. Patient was then
placed in the Trendelenburg position for starting the technique.
J-tip 0.035 inch guide wire was passed under ultrasound
guidance up to the SFJ. A 5-F long introducer sheathwas placed
into the GSV over the guide wire. The introduced length of the
sheath ranged from 36 cm to 50 cm depending on the length of
GSV to be treated. The bare-tipped fiber 600-lm diameter
(ARC laser, Nuremberg, Germany) connected to a 980-nm
diode laser (Fox III ARC laser, Nuremberg, Germany, Fig. 1)
was introduced through the sheath. The device was set with
10 W power and pulsed mode manner 2 s (on) and one second
(off). The distal tip of the laser fiber was positioned 2 cm below
the SFJ under duplex sonographic guidance and confirmed by
direct visualization of the red aiming beam of the laser fiber
tip through the skin. Peri-venous tumescent anesthesia was
injected into the fascial space surrounding the GSV under cross
sectional sonographic guidance along its length (Fig. 2). The
amount of tumescent anesthetic solution was about 400–
500 cc. The component of tumescent anesthesia was 20–25 ml
lidocaine 2% buffered with 1.4% sodium bicarbonate in
500 cc saline 0.9%.
Then allowing the laser energy to be fired and then the laser
fiber and sheath were slowly pullback till they reached one cen-
timeter above the site of puncture to avoid skin burn. The
mean energy applied was 66 J/cm for GSV diameters ranged
between 4 and 9 mm. Simultaneous complementary foam scle-
rotherapy to the distal segment of GSV and remaining branch
varicosities was done in 19 patients (67%) using 4–10 ml foam
by the use of polidocanol 2–3% (Aethoxysklerol, Kreussler,
Germany) while EVLT alone was done in 6 patients (20%).
Bandage compression was applied postoperatively for 24 h
then patients were asked to wear full-thigh class II compres-
sion stockings (30–40 mmHg) for one week.
Patients were instructed to walk immediately after the pro-
cedure and to continue their normal daily activities. All
patients received routinely non-steroidal anti-inflammatory
drugs e.g.: diclofenac potassium or piroxicam for one week.
2.2. Patient follow-up
– Patients were re-examined one week, 1, 2 and 3 months
postoperatively. Patients were evaluated each visit clinically
and by duplex ultrasound to assess symptomatic improve-
ment, patient satisfaction, saphenofemoral incompetence
and observe any procedure related side effects.
Fig. 2 Shown is passage of the guide wire after cannulation of
GSV with hypoechoic tumescent anesthesia seen surrounding the
vein.
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ecchymosis, palpable induration, paresthesia and DVT.
Any criteria of these manifestations were recorded.
2.3. Procedure outcome
Treatment success was defined as symptomatic improvement
as well as decrease in vein diameter, hyperechoic thickening
of vein wall and no flow within the occluded lumen by duplex
examination (Fig. 3). Further follow-up through duplex ultra-
sound by time revealed complete disappearance of the GSV or
minimal residual fibrous cord with no detectable flow. Treat-
ment failure was defined as persistent patency or recanalization
of the treated segment of GSV with no clinical improvement.Fig. 3 Longitudinal color Doppler shows shrinkage of GSV
diameter immediately after the procedure with no color flow seen
within the vein.3. Results
Successful percutaneous access and placement of the sheath
with laser fiber were achieved in all patients. The procedure
was well tolerated by all patients. The mean GSV diameter
measured in upright position, was 6.5 mm (range from 4 to
8 mm). The mean length of GSV treated was 44.2 cm (range
from 38 to 50 cm).
Immediate postoperative successful occlusion that is
defined as absence of flow by duplex ultrasound, was noted
in 29 GSVs (97%). Failure occurred only in one case with large
vein (GSV diameter > 0.8 cm). Minimal residual cord was
noted in 20% of patients at the 1-month follow-up followed
by complete disappearance of the GSV few months later.
Mean energy applied was 66 J/cm.
Postoperative pain was reported in 3 patients (12%) during
the first week and they received analgesics for another one
week. Ecchymosis was seen in 18 patients (72%) and disap-
peared within 1–2 weeks. Palpable indurations were observed
in 2 patients (6%) who resolved within two weeks postopera-
tively. No paresthesia, superficial burns or DVT was detected
(Table 1).
4. Discussion
Performing endovenous laser ablation of the GSV without dis-
section at SFJ is considered a cardinal rule in saphenous vein
surgery that each of the tributaries must be individually
divided. Surprisingly, endovenous laser ablation procedures
have shown lower recurrence rates than with ligation and
stripping.
In our study, successful percutaneous access and placement
of the sheath with laser fiber were achieved in all patients.
Immediate postoperative successful occlusion that is defined
as absence of flow by duplex ultrasound, was noted in 29 GSVs
(97%). Failure occurred only in one case with large vein (GSV
diameter > 0.8 cm).
In addition to the potential risks of surgery and anesthesia
needed for ligation and stripping, surgical treatment for the
GSV is not free from recurrence. Sarin et al. (3) reported
18% rate of recurrent GSV reflux after ligation and stripping
while 45% recurrence rate after high ligation alone which
appeared as early as 3 months after treatment (3). Similarly,
Dwerryhouse et al. (13) found a recurrence rate of 29% after
ligation and stripping of the GSV while 71% after high ligation
alone (13).
Less invasive treatment alternatives aim to reduce risk,
morbidity, and cost while leading to acceptable short and
long-term results. Less invasive treatment alternatives include
ultrasound guided foam sclerotherapy, bipolar radiofrequency
as well as EVLT (14).Table 1 Postoperative complications.
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drainage in competent tributaries while removing only the
abnormal refluxing segments do not stimulate neovasculariza-
tion (15).
EVLT with a 980-nm diode laser system is clinically safe,
feasible, well-tolerable technique without scar and allows peo-
ple to return to their normal daily activities immediately (16).
Although the number of patients treated with EVLT in this
study was relatively small with a short-term follow-up dura-
tion, it was noted that other studies were also similar in the
small number of patients or short term follow-up duration,
such as Navarro et al. (15), who performed his study on 40
patients for a duration of 14 month, Kim et al. (16), who stud-
ied 48 patients for 6 month duration, and Oh et al. (9), who
followed 12 patients for 3 months. Also both Sharif et al.
(17), and Proebstle et al. (18), had followed their patients for
12 month.
Our early results with EVLT have been similar to Duran
(19), who treated 517 GSV and reported closure rate of 98%
after follow-up period of 24 months. Other similar results were
obtained from Min et al. (5), and Sadick and Wasser (20), who
reported similar closure rate around 98%.
Comparing results of EVLT with those of other less inva-
sive techniques, Kanter and Thibault (21), had reported ultra-
sound guided foam sclerotherapy efficacy rate of 75–80% in
expert hands after one year follow-up while Manfrini et al.
(14), had demonstrated recanalization rate of 10% at a mean
follow-up of 4.7 months by the use of radiofrequency.
Trendelenburg positioning of the treated limb as well as
adequate tumescent anesthetic solution is very important to
empty the vein from blood because the presence of blood
reduces the light transmitted to the vein wall. In such circum-
stances vein closure will occur by thrombosis and then throm-
bus dissolution leads to recanalization (22). Tumescent
anesthesia is essential for EVLT making this procedure safe
and painless. About 400–500 cc of fluid was required to be
injected perivenous to be a barrier for surrounding structures
from heat as well as its role in vein compression (23). In this
study, mean energy applied was 66 J/cm. Similar amount of
energy was applied in the studies of Theivacumar et al. (24),
Timperman et al. (25), and Proebstle et al. (26), that reported
60–70 J/cm, 63.4 J/cm and 63 J/cm respectively. Timperman
et al. (25), had published in his study that the use of high
energy about 63.4 J/cm had lower failure rate; however, Kim
et al. (16), reported successful rate equal to that obtained by
Timperman et al., in spite of using lower energy about
32.5 J/cm.
Discrepancy in the energy delivered during EVLT reflects
the hypothesis of Proebstle et al. (26), that to achieve reliable
ablation of GSV, we required two factors: quantity of energy
delivered and vein diameter. On the contrary, Kim et al.
(16), had reported that there was no significant difference in
success rate or failure rate between higher and lower amount
of laser energy, so higher energy was not necessary as it theo-
retically led to more side effects e.g. superficial burns and pal-
pable indurations.
We used the pulsed mode as it was our early experience. As
pulsed mode of endovenous laser ablation had induced bruis-
ing in most of patients, Proebstle et al. (27) suggested the use of
continuous pullback mode of the laser fiber with proper speed.
Continuous pullback of laser fiber could avoid perforation of
the vein wall and produce more destruction of the venous wall;however, too slow pullback could produce a longitudinal cut in
the venous wall and too rapid pullback could produce incom-
plete occlusion (28).
Gibson et al. (29), reported pain in 97% of treated patients,
and also Proebstle et al. (27), confirmed that 72% of patients
complained of pain.
We are coincident with Rasmussen who stated that nomajor
complication was reported such as DVT (30). Postoperative
pain varied from being sore, discomfort to mild pain. Sharif
et al. (17), had reported that pain felt by patients occurred
5–8 days after the procedure and was related to the inflamma-
tion resulting from successful endovenous laser ablation but
not related to ecchymosis nor damage to perivenous tissue.
In their series, pain was treated with analgesics twice daily
for 1–2 weeks.
In our study, analgesics were routinely given to patients for
one week before feeling of pain, that can explain why postop-
erative pain occurred only in 12% of patients and they
required another one week duration of analgesics.
Ecchymosis occurred in our study in 18 patients (72%),
which was similar to Sadick et al. (20), who reported 61.7%
and Proebstle et al. (27), who reported 73.2%. Ecchymosis
may be attributed to various causes but mostly due to laser
induced microvessel perforation, extravasation of blood into
surrounding tissues, and multiple subcutaneous injections of
tumescent anesthetic solution (29).
Indurations occurred in our study in 2 patients (8%) and
these were similar to those occurred in Min et al. (5), who
reported 5% incidence. These results hypothesize that deliv-
ered energy should be calculated according to the GSV diam-
eter to obtain high rate of GSV closure with minimal thermal
side effects.
Failure of the procedure was defined as persistent patency
or recanalization of the treated segment with no clinical
improvement. Failure was observed in our study in one case
when GSV diameter was >0.8 cm. It was discovered during
follow-up visits after first week and 1 month and considered
failed procedure after 3 months. This patient refused repeating
the technique and was treated by ligation and stripping. We
await longer-term follow-up results from our patients already
treated with EVLT and evaluation of other new cases. This
may offer a good alternative technique to ligation and strip-
ping for those patients wishing to avoid or afraid of surgery.
The limitations of our study include a relatively small num-
ber of patients treated with EVLT, further studies may need to
expand this number, and the second limitation was the absence
of a long term follow-up.
In conclusion EVLT for GSV reflux appears to be safe, fea-
sible and efficient outpatient technique. With proper patient
selection, EVLT can be considered as a successful method
for treating superficial vein reflux and may replace the tradi-
tional surgical treatment. Long-term follow-up is awaited.Author contribution
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